| Literature DB >> 27303721 |
Amelia E Barber1, Brittany A Fleming1, Matthew A Mulvey1.
Abstract
In individuals with sepsis, the infecting microbes are commonly viewed as generic inducers of inflammation while the host background is considered the primary variable affecting disease progression and outcome. To study the effects of bacterial strain differences on the maladaptive immune responses that are induced during sepsis, we employed a novel zebrafish embryo infection model using extraintestinal pathogenic Escherichia coli (ExPEC) isolates. These genetically diverse pathogens are a leading cause of sepsis and are becoming increasingly dangerous because of the rise of multidrug-resistant strains. Zebrafish infected with ExPEC isolates exhibit many of the pathophysiological features seen in septic human patients, including dysregulated inflammatory responses (cytokine storms), tachycardia, endothelial leakage, and progressive edema. However, only a limited subset of ExPEC isolates can trigger a sepsis-like state and death of the host when introduced into the bloodstream. Mirroring the situation in human patients, antibiotic therapy reduced ExPEC titers and improved host survival rates but was only effective within limited time frames that varied, depending on the infecting pathogen. Intriguingly, we find that phylogenetically distant but similarly lethal ExPEC isolates can stimulate markedly different host transcriptional responses, including disparate levels of inflammatory mediators. These differences correlate with the amounts of bacterial flagellin expression during infection, as well as differential activation of Toll-like receptor 5 by discrete flagellar serotypes. Altogether, this work establishes zebrafish as a relevant model of key aspects of human sepsis and highlights the ability of genetically distinct ExPEC isolates to induce divergent host responses independently of baseline host attributes. IMPORTANCE Sepsis is a life-threatening systemic inflammatory condition that is initiated by the presence of microorganisms in the bloodstream. In the United States, sepsis due to ExPEC and other pathogens kills well over a quarter of a million people each year and is associated with tremendous health care costs. A high degree of heterogeneity in the signs and symptomology of sepsis makes this disease notoriously difficult to effectively diagnose and manage. Here, using a zebrafish model of sepsis, we find that similarly lethal but genetically distinct ExPEC isolates can elicit notably disparate host responses. These variances are in part due to differences in the levels and types of flagellin that are expressed by the infecting ExPEC strains. A better understanding of the variable impact that bacterial factors like flagellin have on host responses during sepsis could lead to improved diagnostic and therapeutic approaches to these often deadly infections. Podcast: A podcast concerning this article is available.Entities:
Keywords: Escherichia coli; ExPEC; TLR5; bacteremia; bloodstream infections; cytokine storm; flagellin; sepsis; zebrafish
Year: 2016 PMID: 27303721 PMCID: PMC4894679 DOI: 10.1128/mSphere.00062-16
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389
FIG 1 Few E. coli isolates can proliferate in the bloodstream and cause host death. (A) Lethality of nonpathogenic reference E. coli strains, reference ExPEC strains, and uncharacterized clinical isolates in zebrafish embryos 24 h following the injection of ~1,000 CFU into the bloodstream. Bars indicate the average percentages (± the standard error of the mean) of fish that were killed; n = 30 to 60 embryos pooled from two to four experiments. (B) Bacterial burdens in infected embryos at 0, 6, and 12 hpi. Data from two independent experiments were pooled. Lines mark median values; n = 5 to 10 embryos per time point. NS, no significant difference between CFT073 and F11 titers detected at any time point, as determined by Student’s t test.
FIG 2 Distinct pathologies associated with different but equally lethal ExPEC isolates. (A) An F11-infected embryo displaying characteristic pericardial edema (arrowhead) at 12 hpi. This is not seen following the injection of controls with PBS (left). (B) A CFT073-infected embryo at 12 hpi showing fin erosion and ulceration commonly seen during infection with either CFT073 or F11. (C) F11-infected embryos, but not those infected with CFT073, often develop protrusions (arrowhead) in the trunk or tail region by 12 hpi. (D) Merged bright-field and fluorescent images of an F11/pGEN-GFP(LVA)-infected embryo at 12 hpi showing bacteria at the base of a protrusion (inset) but not within the main structure. (E) Bright-field and matched fluorescent images of F11-infected embryos stained with acridine orange (green) at 12 hpi. The dye accumulates within protrusions on the trunk (left, Chevron) and tail (right, arrows). (F) Bright-field (top) or fluorescent (bottom) images of Tg(krt8:GFP) embryos at 12 hpi with F11. Epithelial cells within this transgenic line express GFP. Each arrowhead marks an F11-induced protrusion. (G) Merged bright-field and fluorescent images of Tg(fli1a:GFP) embryos at 12 hpi with F11. Endothelial cells and leukocytes in this transgenic line express GFP. Protrusions are indicated by arrowheads.
FIG 3 Survival of ExPEC-infected embryos varies with ciprofloxacin treatment. (A and B) Kaplan-Meier survival curves of zebrafish embryos injected via the circulation valley with F11 (A) or CFT073 (B) and then treated with ciprofloxacin at the times indicated; n = 15 to 20 embryos. Black solid lines show untreated controls. (C and D) Bacterial titers recovered from F11 (C)- and CFT073 (D)-infected embryos before and after treatment with ciprofloxacin at 12 or 3 hpi, as indicated. Bars denote the median values of the groups; n ≥9 embryos pooled from two independent experiments. (E and F) Uninfected controls and F11-infected embryos at 24 (E) and 72 (F) hpi. Both control and F11-infected zebrafish were treated with ciprofloxacin beginning at 12 hpi. The arrowhead in panel E indicates the presence of pericardial edema in a surviving F11-infected embryo. (G) Percentages of surviving embryos with overt signs of edema at 48 and 72 hpi of the bloodstream with F11 or CFT073. Ciprofloxacin was administered at 3, 6, or 12 hpi, as indicated. Uninfected controls were treated with ciprofloxacin at the same time points. Bars represent mean data ± the standard error of the mean from two independent experiments; total n = 30 to 40 fish. ND, not detected.
FIG 4 Equally lethal ExPEC isolates trigger distinct host responses. (A and B) Venn diagrams indicating the numbers of host genes that are differentially expressed in zebrafish embryos at 6 (A) or 12 (B) hpi with CFT073 versus F11, as determined by microarray analysis. The number of differentially expressed transcripts was calculated for each data set by gating on probes with ≥2-fold changes relative to mock-infected (PBS-injected) controls and P ≤ 0.05. Results from multiple probes that mapped to the same gene were combined to generate nonredundant lists of the differentially expressed genes. Arrows below the Venn diagrams denote transcripts that were up- or downregulated relative to controls. (C) The numbers of differentially expressed host genes in a selected list of enriched GO terms, as determined by DAVID.
Gene sets that are differentially expressed in zebrafish embryos because of systemic infection with ExPEC are functionally similar to many of those that are changed in human patients with sepsis
| Functional category | Gene products | Links to human sepsis |
|---|---|---|
| Signal transduction | ||
| Pattern recognition | TLR5, MARCO scavenger receptor, | |
| NF-κB | Rel, NF-κB2, NF-κBIa (IκBα), Bcl3, | |
| MAP kinase | Fos, Jun, ATF-3, MEKK5, TRAF1/2b, | |
| Jak-STAT | Jak1, STAT4, STAT1b, STAT3, IRF9 | |
| Proinflammatory | TNF-α/β, TNF receptors (TNFRSF1a and | |
| Anti-inflammatory | SOCS1/3, IL-10, galectin-1, IRAK3 | |
| Acute-phase proteins | SAA1, HAMP1, haptoglobin, hemopexin | |
| Coagulation and | Coagulation factor IIIb, fibrinogen, | |
| Protease activities | MMP9/13/30, proteasome subunits, | |
| ROS | Neutrophil cytosolic factor 1 (p47-PHOX), | |
| Apoptosis | Caspase 8, Fas, MEKK5 (ASK-1), CFLAR, | |
| Arachidonic acid | Prostaglandin-endoperoxide synthase 1 |
Transcript levels for the gene products indicated are significantly increased ≥2-fold (P < 0.05) in F11- and/or CFT073-infected zebrafish embryos at 6 and/or 12 hpi, relative to those in mock-infected controls.
The reference numbers listed are those of studies that implicate the specified functional categories or selected gene products in human sepsis and related syndromes but do not necessarily include all of the pertinent publications.
ROS, reactive oxygen species.
FIG 5 Variable expression of cytokines and host defense genes in response to lethal and nonlethal E. coli strains. (A to I) qRT-PCR analysis of the specified cytokine transcripts at 6 and 12 hpi with PBS or ~1,000 CFU of the E. coli strains indicated. Each bar represents mean results ± the standard error of the mean from three or four pools of ≥16 embryos. A qRT-PCR assay of each pool was carried out with technical duplicates. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001 (versus PBS-injected controls, as determined by Student’s t test). P values for F11- versus CFT073-infected samples are also indicated.
FIG 6 The differential effects of CFT073 and F11 on host responses are recapitulated in a mouse model of sepsis. (A to C) Bacterial titers recovered from the kidneys, livers, and spleens of outbred Swiss-Webster mice at 6 and 12 hpi with ~108 CFU of CFT073 or F11 via subcutaneous injection. Data from two independent experiments were pooled; total n = 10 mice per time point. Horizontal lines indicate median values. CFT073 and F11 titers were not significantly different at any time point, as determined by the Mann-Whitney U test. (D) Serum IL-6 levels in mice at 6 and 12 hpi with PBS, CFT073, or F11, as determined by enzyme-linked immunosorbent assay. Data are representative of mean results ± the standard error of the mean from two independent experiments; n = 5 mice. The gray dotted line shows the limit of quantification. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001 (versus PBS-injected controls, as determined by Student’s t test). P values for F11- versus CFT073-infected mice are also indicated. (E) IL-6 transcript levels in zebrafish embryos at 6 and 12 hpi with PBS, F11, or CFT073, as determined by qRT-PCR. Each bar represents the mean value ± the standard error of the mean of three independent experiments, each with 15 to 20 embryos. A qRT-PCR assay of each pool was performed with technical duplicates.
FIG 7 Flagellins from CFT073 and F11 have differential effects on TLR5 activation. (A) Alignment of the sequences of the FliC proteins of CFT073 (H1) and F11 (H31). The sequences are 67.3% similar. Identical residues are shaded gray. Predicted TLR5 binding regions are indicated by blue lines and bold text. (B) Bacterial burdens in infected embryos at 12 hpi with ~1,000 CFU of the strains indicated. Data were pooled from two independent experiments. Bars denote median values; n = 10 embryos. No significant differences between wild-type and fliC mutant strains were detected by Mann-Whitney U tests. (C, D) qRT-PCR analysis of the cytokine transcripts specified at 12 hpi with PBS or ~1,000 CFU of the E. coli strains indicated. Bars indicate mean results ± the standard error of the mean from three pools of 18 to 20 embryos. qRT-PCR for each pool was carried out with technical duplicates. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001 (versus PBS-injected controls, as determined by Student’s t test). P values for wild-type versus fliC mutant samples are also indicated. (E) Levels of FliC expression in infected embryos at 9 and 12 hpi, as determined with the pfliC-lux reporter construct. Lines mark median values; n = 30 to 50 embryos pooled from two independent experiments. P values were calculated by Mann-Whitney U tests. (F) Bacterial burdens in infected embryos at 12 hpi with ~2,000 to 2,500 CFU of CFT073 or F11 carrying pfliC-lux. Larger inoculation doses were used to compensate for the partial loss of fitness of strains carrying pfliC-lux. Data from two independent experiments were pooled. Lines mark median values; n = 10 embryos. ****, P ≤ 0.0001 (as calculated by Mann-Whitney U test). (G) Immunoblot assay showing adjusted levels of FliC in flagellar preparations from CFT073, CFT073ΔfliC, F11, and F11ΔfliC. (H) TLR5 stimulation by flagellar preparations, as measured with HEK-Blue mTLR5 reporter cells. Bars represent mean results ± 95% confidence intervals from two independent experiments with three replicates. ****, P ≤ 0.0001 (versus the PBS control, as determined by Student’s t test). P values for wild-type versus fliC mutant samples and CFT073 versus F11 are also indicated. (I) TLR5 stimulation by semipurified flagella in the presence of a TLR5 neutralizing or control antibody, as measured with HEK-Blue mTLR5 reporter cells. Bars represent mean results ± 95% confidence intervals from three independent experiments with three replicates. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001 (versus the PBS control, as determined by Student’s t test). P values for the TLR5 neutralizing antibody versus the control antibody and CFT073 versus F11 are also indicated.